NO171066C - Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrobenzo(b)thiofener - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrobenzo(b)thiofener

Info

Publication number
NO171066C
NO171066C NO863140A NO863140A NO171066C NO 171066 C NO171066 C NO 171066C NO 863140 A NO863140 A NO 863140A NO 863140 A NO863140 A NO 863140A NO 171066 C NO171066 C NO 171066C
Authority
NO
Norway
Prior art keywords
thiophenes
dihydrobenzo
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO863140A
Other languages
English (en)
Norwegian (no)
Other versions
NO863140L (no
NO863140D0 (no
NO171066B (no
Inventor
Dinanath Fakir Rane
Russel Edwin Pike
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO863140D0 publication Critical patent/NO863140D0/no
Publication of NO863140L publication Critical patent/NO863140L/no
Publication of NO171066B publication Critical patent/NO171066B/no
Publication of NO171066C publication Critical patent/NO171066C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO863140A 1985-08-12 1986-08-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrobenzo(b)thiofener NO171066C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/764,289 US4731364A (en) 1985-08-12 1985-08-12 Dihydrobenzo(B)thiophenes and pharmaceutical compositions thereof useful as antifungals

Publications (4)

Publication Number Publication Date
NO863140D0 NO863140D0 (no) 1986-08-04
NO863140L NO863140L (no) 1987-02-11
NO171066B NO171066B (no) 1992-10-12
NO171066C true NO171066C (no) 1993-01-20

Family

ID=25070267

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863140A NO171066C (no) 1985-08-12 1986-08-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrobenzo(b)thiofener

Country Status (24)

Country Link
US (1) US4731364A (fr)
EP (1) EP0212428B1 (fr)
JP (1) JPS6248683A (fr)
KR (1) KR900000673B1 (fr)
CN (1) CN1022105C (fr)
AR (1) AR244224A1 (fr)
AT (1) ATE53390T1 (fr)
AU (1) AU585381B2 (fr)
CA (1) CA1287634C (fr)
DE (1) DE3671748D1 (fr)
DK (1) DK370886A (fr)
ES (1) ES2001866A6 (fr)
FI (1) FI95251C (fr)
GR (1) GR862058B (fr)
HU (1) HU209302B (fr)
IE (1) IE59028B1 (fr)
IL (1) IL79598A0 (fr)
MY (1) MY101809A (fr)
NO (1) NO171066C (fr)
NZ (1) NZ217081A (fr)
OA (1) OA08374A (fr)
PH (1) PH23405A (fr)
PT (1) PT83151B (fr)
ZA (1) ZA865841B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695579A (en) * 1984-12-21 1987-09-22 Schering Corporation Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens
US4943311A (en) * 1988-05-09 1990-07-24 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352808A (en) * 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
US4431816A (en) * 1980-12-12 1984-02-14 Schering Corporation 2,3-Dihydro-2-(imidazolylmethyl)benzo(b)thiophenes
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4695579A (en) * 1984-12-21 1987-09-22 Schering Corporation Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens

Also Published As

Publication number Publication date
DE3671748D1 (de) 1990-07-12
CA1287634C (fr) 1991-08-13
CN1022105C (zh) 1993-09-15
IE862104L (en) 1987-02-12
CN86105964A (zh) 1987-03-11
HUT44784A (en) 1988-04-28
DK370886D0 (da) 1986-08-04
GR862058B (en) 1986-12-24
JPS6248683A (ja) 1987-03-03
AU585381B2 (en) 1989-06-15
EP0212428B1 (fr) 1990-06-06
NO863140L (no) 1987-02-11
NO863140D0 (no) 1986-08-04
FI863168L (fi) 1987-02-13
FI95251C (fi) 1996-01-10
AU6085486A (en) 1987-02-19
IE59028B1 (en) 1993-12-15
OA08374A (fr) 1988-02-29
PH23405A (en) 1989-07-26
DK370886A (da) 1987-02-13
PT83151B (pt) 1989-03-30
ZA865841B (en) 1987-03-25
AR244224A1 (es) 1993-10-29
EP0212428A1 (fr) 1987-03-04
KR870002133A (ko) 1987-03-30
FI863168A0 (fi) 1986-08-04
IL79598A0 (en) 1986-11-30
HU209302B (en) 1994-04-28
FI95251B (fi) 1995-09-29
ES2001866A6 (es) 1988-07-01
KR900000673B1 (ko) 1990-02-02
ATE53390T1 (de) 1990-06-15
MY101809A (en) 1992-01-31
NO171066B (no) 1992-10-12
PT83151A (en) 1986-09-01
US4731364A (en) 1988-03-15
NZ217081A (en) 1989-11-28

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO170085C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (benzofuran-2-yl)imidazoler
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO865012D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO170012C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
NO168357C (no) Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider